Financial News Feed

Weaker Buy Today ABMD ranks #132 as BUY CANDIDATE. Stronger Buy
Today ABMD ranks #132 as BUY CANDIDATE.

ABMD stock ABIOMED

ABMD stock
ABIOMED

Taking a closer look at shares of Abiomed Inc (ABMD), we can see that the beta research opinion is presently Buy. This signal uses a system combining volatility, momentum, and wave theory to help spot...

Read more

BTIG Research reiterated their buy rating on shares of ABIOMED (NASDAQ:ABMD) in a research report released on Tuesday morning, The Fly reports. BTIG Research currently has a $400.00 price objective on...

Read more

BTIG Research restated their buy rating on shares of ABIOMED (NASDAQ:ABMD) in a research note published on Tuesday, The Fly reports. The firm currently has a $400.00 price target on the medical equipm...

Read more

EPS is commonly considered to be one of the most important factors when evaluating the price of a share. Taking a look at the current quarter consensus earnings per share estimate provided by Zacks Re...

Read more

Investors may be focusing on technical signals for Abiomed Inc (ABMD). Taking a look at the longer-term MACD oscillator indicator, we note that the reading is currently Sell. The MACD is generally use...

Read more

Analyst Ratings For ABIOMED, Inc. (NASDAQ:ABMD) Today, BTIG Research reiterated its Buy rating on ABIOMED, Inc. (NASDAQ:ABMD) with a price target of $400.00. There are 8 Buy Ratings, no Strong Buy Rat...

Read more

Strong contribution from Impella product line is likely to provide Abiomed (ABMD) a competitive edge in the MedTech space....

Read more

ABIOMED (NASDAQ:ABMD)‘s stock had its “buy” rating reaffirmed by equities research analysts at BTIG Research in a research note issued to investors on Tuesday, The Fly reports. They currently ha...

Read more

Zacks Investment Research upgraded shares of ABIOMED (NASDAQ:ABMD) from a hold rating to a buy rating in a research note published on Friday morning. They currently have $370.00 price objective on the...

Read more

Monitoring some price target data, we have noticed that shares of ABIOMED, Inc. (NASDAQ:ABMD) currently have an average target of $438. This number is the consensus target price averaging estimates pr...

Read more

Abiomed (ABMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....

Read more

Does Abiomed (ABMD) have what it takes to be a top stock pick for momentum investors? Let's find out....

Read more

Taking a closer look at technical signals for Abiomed Inc (ABMD), we can see that the short-term moving average Hilo channel is presently Buy. This indicator calculates the moving average based on hig...

Read more

ABIOMED, Inc. (ABMD) has an ERP5 rank of 3320. The ERP5 score was designed by the MFIE Capital team. It combines the Greenblatt Magic formula with ideas developed by Graham & Dodd, who advocated the u...

Read more

Abiomed Inc (ABMD)’s closing price of $333.74 has closed above it’s Parabolic SAR reading, indicating a potential trend reversal. Parabolic SAR (or PSAR) is a simple, compact indicator that can pr...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank